Gisèle Chvetzoff

Learn More
BACKGROUND Previous studies have suggested that placebo treatment can have positive effects on a variety of disorders and disease-related symptoms. However, the methodology used to collect and interpret the data may not have been ideal, because the studies were not double-blinded or the endpoints were not properly validated. The purpose of the present study(More)
version of the Standards, Options and Recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002) All patients have the right to expect to receive the best therapeutic means available to reduce their suffering. Recent evaluation of the French ministerial 3-year plan for the fight against pain by the(More)
UNLABELLED A MAJOR CHALLENGE: Prevention of short and long term toxicity of chemotherapy is an important challenge in oncology in order to maintain the dose/intensity of protocols and to increase patient comfort. AVAILABLE CHEMOPROTECTORS Amifostine protects against the blood, kidney and nerve toxicity of cisplatin. Protection is less evident for(More)
We aimed to validate prognostic scores for survival in patients undergoing chemotherapy for advanced or metastatic cancer after first-line treatment. We previously described two models with good prognostic value based on a combination of Performance Status (PS) and either lactate dehydrogenase (LDH) level or lymphocyte count. These factors were evaluated(More)
This study aimed to determine factors favoring home death for cancer patients in a context of coordinated home care. A retrospective study was conducted among patients followed up by the home care coordinating unit of the cancer center of Lyon. The main endpoint was place of death. Univariate analysis included general characteristics (age, gender, rural or(More)
Le centre régional de lutte contre le cancer de Lyon a développé un service de coordination des soins à domicile (CSAD) basé dans l’hôpital mais largement ouvert sur la ville. Analyse descriptive de l’organisation de la CSAD et de son activité en 2003. La sortie de l’hôpital est initiée par l’oncologue référent du patient. Après accord du patient et de ses(More)
La loi du 4 mars 2002 relative aux droits des malades a introduit dans le droit français la notion de personne de confiance. Un malade peut ainsi désigner une personne qui l'accompagne, le représente et traduit ses volontés si lui-même ne peut plus le faire. La loi du 2005 sur la fin de vie a ajouté la notion de directives anticipées, permettant à une(More)
This literature review aims to synthesize available studies and to update findings in order to obtain a current, comprehensive estimate of the benefits of pain education. Forty-four original articles obtained from the PubMed database were analyzed to investigate which protocols could be most effective in improving pain management. Recent studies indicate a(More)
The preferences of advanced cancer patients and the impact of cancer management on relatives remain partly unknown. We present the preliminary results of a prospective study evaluating quality of care (QC), quality of life (QoL) and family impact (FI) in advanced cancer patients treated at home or in hospital, depending on their own choice. QC is evaluated(More)
The French Cancer Centers (FCC) have a threefold mission, care research and education. Their specificity is multidisciplinary and comprehensive patient support at all stages of cancer. Innovation and research are at the heart of FCC action, but the care of patients in the palliative phase is a major and long-time concern. In each center there is an(More)